Company Renaming Annoucement 2024-05-21

Vision and Culture
Mission

Mission

To safeguard the human health

Vision

Vision

Through unremitting long-term efforts, we aim to become a domestic leading and internationally renowned innovative vaccine corporate.

Value

Value

Rigorous and pragmatic, Striving for perfection, Pursuing excellence, Collaborating for mutual benefit.

about

Our Company

LakeShore Biopharma (Nasdaq:LSB, formerly YS) is a developer and manufacturer of human-used vaccines and other immune products. At present, the main product under sale is freeze-dried human rabies vaccine (Vero cells), and the cumulative sales of this product since its launch have exceeded 80 million units.The therapeutic PIKA rabies vaccine (Vero cells) jointly developed by the corporate is a major new drug development project of Ministry of Science and Technology of Ch

Media Coverage